ArticleFrontiers in medicine2023

Considerations for the use of immunosuppression for the management of pemphigus during the COVID-19 pandemic with a focus on rituximab: Case reports from a single center experience in Australia.

Ben Koszegi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.